Drugs / Insulin producing stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06951074 | Apr 2025 → May 2026 overdue | type 1 diabetes mellitus | Ain Shams University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin producing stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06951074 ↗ |
| Action | Restore | “reconstitute pancreatic endocrine function” NCT06951074 ↗ |